Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02868177Phase 2/3Completed
Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
DiseaseHypertriglyceridemiaInsulin Resistance+3 more
PrincipalinvestigatorStart date: 2016-10-01

Research Network

Collaboration Network

5 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jean-Marie BARD, Dr-PhD

UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France

Very Similar
2 trials

Shared therapeutic areas:

HypertriglyceridemiaDiseaseHypercholesterolemia+4 more

Worked with same sponsors:

Biofortis Mérieux NutriSciencesInstitut Pasteur de Lille+1 more
Collaborated on 2 trials
Similarity Score78%

Sébastien L Peltier, PhD

Valbiotis

Similar
2 trials

Shared therapeutic areas:

DiseaseHypertriglyceridemiaInsulin Resistance+3 more

Worked with same sponsors:

Biofortis Mérieux NutriSciencesInstitut Pasteur de Lille+1 more
Collaborated on 1 trial
Similarity Score64%

Sébastien Peltier, PhD

Valbiotis

Related
2 trials

Shared therapeutic areas:

HypercholesterolemiaHypertriglyceridemia

Worked with same sponsors:

Biofortis Mérieux NutriSciencesValbiotis
Collaborated on 1 trial
Similarity Score24%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Prediabetic StateDiabetes Mellitus, Type 2Hypercholesterolemia+1 more
Similarity Score17%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityInsulin ResistanceDiabetes Mellitus, Type 2+1 more
Similarity Score17%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

HypercholesterolemiaDiabetes Mellitus, Type 2Obesity
Similarity Score13%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2Prediabetic State
Similarity Score13%

Adrian Vella, MD

Mayo Clinic

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2ObesityPrediabetic State
Similarity Score13%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityPrediabetic State
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityInsulin Resistance
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02868177Phase 2/3PrincipalInvestigator

Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes

DiseaseHypertriglyceridemiaInsulin Resistance+3 more
Completed
NCT02989753Phase 1/2PrincipalInvestigator

Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia

HypercholesterolemiaHypertriglyceridemia
Completed

All 2 trials loaded